Introduction
============

Dyspepsia, a collection of symptoms referable to the upper gastrointestinal tract (GI), is a global concern. It is known to have a prevalence rate ranging from 14%-30% in both the West and in Asia.[@B1]-[@B4] This would be a major problem if dyspepsia resulted in the reduction of the life span of individuals with the condition. However, as the majority of cases have functional disease, dyspepsia is rarely fatal.[@B5] Nevertheless, dyspepsia has been shown to exert a significant impact on health-related quality of life[@B6] in lieu of its chronic, relapsing natural history[@B7] and the lack of effective therapy for symptom control.[@B8]

While health-related quality of life is one method of examining the impact of dyspepsia, the financial costs or the economic burden that it incurs is another. To date, very few studies have made an attempt to estimate the true economic impact of dyspepsia. Some studies have not made an actual cost analysis, but have implied the economic burden of dyspepsia by documenting healthcare utilization and loss of productivity.[@B9]-[@B11] The true cost of any disease or condition is known to broadly consist of direct medical costs, ie, the cost of the treatment, medical consultation and hospitalization etc, used in the management of an individual, and indirect costs, which include costs to the patient and society as a result of loss of employment. The latter is generally implied by the amount of time off work, usually measured in days, resulting from the illness/condition. Additional intangible costs of dyspepsia, as a result of its\' impact on quality of life, is further often neglected in economic analyses, as this data is difficult to obtain.

The actual cost of dyspepsia, from both health-service costs and loss of productivity will inevitably vary from different parts of the globe, depending on local health-care costs and labour wages. To date, there is a lack of data on the economic impact of dyspepsia in Asia, the world\'s most populous continent. Healthcare provision in many parts of Asia is diverse, with significant differences and disparities between urban and rural areas. Malaysia is a developing, multi-ethnic Asian country of 26 million residents, comprising of 3 major distinct ethnic groups, namely Malays (51%), Chinese (27%) and Indians (8%).[@B12] Almost half (44%) of the population reside in rural areas and the ethnic distribution between urban and rural population is distinctly varied.[@B12] The government of Malaysia does not have a health insurance care system provision for all. It has a subsidised public healthcare system, which is the same for both rural and urban areas, but there are differences in delivery.[@B13] The private healthcare system is mostly paid by individuals \"out of pocket,\" ie, by cash. Some adults have insurance, but that is entirely dependent on the individual and not compulsory for all.

We had previously conducted epidemiological studies on dyspepsia in both representative rural and urban populations in this country and these results have been reported elsewhere.[@B2],[@B3] The aim of the present study is to estimate the costs of dyspepsia in both rural and urban populations over a 12-month period, utilising data from the population survey.

Materials and Methods
=====================

This study used a cost-of-illness method to calculate the cost to society as a result of dyspepsia.[@B14] A cost-of-illness analysis is a descriptive type of study, relating all costs to a specific disease or event. Cost-of-illness studies use either a prevalence-based or an incidence-based approach. A prevalence-based, \"bottom-up\" estimate of cost-of-illness was performed. The \"bottom-up\" approach usually starts from a selected sub-population with the actual disease and all costs related to the disease are estimated and then extrapolated to the national level. Costing for dyspepsia was calculated on the principle of collecting information on resource consumption and multiplying each resource (quantity) with a unit cost (price). Costs were classified into 3 standard categories of direct, indirect and intangible costs.[@B15]

Study Design
------------

Local institutional ethics approval was obtained prior to the commencement of the study. Details of the study design have been reported previously.[@B2],[@B3] Essentially, a cross-sectional survey was conducted in representative populations in both rural and urban areas within Malaysia between January and October 2007. A population-based stratified sampling method was used to indentify households for the survey.[@B16] The district of Kuala Langat, in the state of Selangor, with a population of 30,009 residents distributed among 9 villages, was chosen for the rural survey as the population in this region was typical of the socio-demographics of rural Malaysia.[@B12] For the urban component of the study, Taman Tun Dr Ismail, a residential area with an estimated population of 25,000 residents situated within the heart of Kuala Lumpur, was selected as the population that typified the ethnic and socio-demographic pattern of urban Malaysia.[@B12]

Dyspepsia was defined according to the Rome II criteria.[@B17] A modified version had previously been translated into the local Malay language (using standard procedures) and validated in a group of Malaysian patients as part of a pan-Asian study on functional GI diseases.[@B18] A structured questionnaire, which included the modified Rome II questions and the EQ-5D (EuroQol, Rotterdam, Netherlands), was used to obtain data in this study ([Appendix](#S1){ref-type="supplementary-material"}, see page 51-57).

Direct and Indirect Costing Valuation
-------------------------------------

Direct costs were calculated based on the actual items spent on healthcare. Consultation practices related to dyspepsia alone was assessed by determining the frequency and type of facility visited over a 3-month period. The time frame of 3 months was chosen in accordance with published literature to minimize recall bias among respondents. Data on regular consumption of medication for dyspeptic symptoms, either bought over-the-counter or prescribed, over a 3-month period was obtained in the questionnaire. To overcome the recognized limitation of public knowledge for drug names, a colour pictorial of tablets (with names) commonly utilized for various GI disorders, designed by this institution\'s pharmacy department, was used by data collectors. The usage of traditional/complementary medicines were additionally enquired and documented. The cost of Western drugs for dyspepsia were based on pharmaceutical retail prices as outlined in the Drug Index of Medical Specialities.[@B19] The cost of traditional Eastern medicines used locally for dyspeptic symptoms were obtained from local suppliers ([Table 1](#T1){ref-type="table"}). Costs of primary and secondary care consultations, investigation procedures and hospital admissions were based on the Malaysian Medical Association 2002/4 procedural code book.

Indirect costs in this study were based on loss of earnings due to work absenteeism as a result of dyspepsia symptoms over a 3-month period. Costs due to premature mortality or retirement as a result of dyspepsia was not included, as dyspepsia has a neglible impact on mortality and is not known to cause long-term disability.

Intangible Costs
----------------

Dyspepsia is recognized to have a significant impairment of health-related quality of life in various populations globally.[@B3],[@B6] As quality of life is an intangible measure of cost, it is often omitted from economic evaluations of chronic diseases. In this study, we used a locally translated[@B20] and validated[@B21] version of the EQ-5D (EuroQol) instrument to determine a composite utility value for various domains of health.[@B22] Based on a 3-month definition of dyspepsia, the utility scores of the EQ-5D were used as an estimate of the number of quality-adjusted life years (QALYs). By imputing a monetary value on each QALY, an estimate of the intangible costs due to dyspepsia was obtained.

Statistical Methods
-------------------

All data was collected and analysed using the Statistical Package for Social Sciences (SPSS version 16; SPSS Inc., Chicago, IL, USA). The total cost of dyspepsia was obtained by summing up the direct and indirect costs. As data for costings were collected for a 3-month period, total dyspepsia cost per year was obtained by extrapolation to 12 months. The cost per QALY for dyspepsia was calculated using the formula: cost per QALY = total cost over 12 months/QALY.[@B15] Continuous data were expressed as means with standard deviation or medians with interquartile range where appropriate. Analysis of continuous parametric data was performed with the Student\'s *t* test. Statistical significance was assumed with a *P*-value of \< 0.05.

Results
=======

Socioeconomic Status of Rural and Urban Population
--------------------------------------------------

The study in both rural and urban populations was conducted between January and December 2007, and the demographic details have been reported separately before.[@B2],[@B3] In the rural area, complete data was collected on a total of 2,000/2,260 (88.5%) adults from a total number of 1,642 homes. The mean age of interviewees was 40.4 ± 15.3 years, 1,255 (62.7%) adults were female, 329 (16.5%) held professional or semi-skilled jobs and the mean income per month was RM1,044.20 ± 727.45 (USD316.40 ± 220.44). In the urban area, the mean age of interviewees was 40.5 ± 11.8 years, 1,137 (55.7%) adults were female, 1,516 (74.3%) held professional or semi-skilled jobs and the mean income per month was RM4,665.20 ± 4,402.25 (USD1,504.90 ± 1,420.10). The socioeconomic status of both study populations are described in [Table 2](#T2){ref-type="table"}.

Cost of Dyspepsia in the Rural Population
-----------------------------------------

Dyspepsia was prevalent in 292 (14.6%) of adults in the rural population. Over a 3-month period, 130/292 (44.5%) adults consumed medications regularly, for a minimum period of 4 weeks. Of these, 78 adults consumed over-the-counter medications, while the rest used medical prescriptions. The type of pharmaceutical and herbal compounds consumed included the following: antacids (n = 112), H~2~ receptor antagonists (n = 8), western herbal (n = 2), anti-spasmodic (n = 2), traditional Malay preparation (n = 4) and traditional Chinese preparation (n = 2). Details of the traditional medications that were used by our local population are highlighted in [Table 3](#T3){ref-type="table"}. One hundred and twenty (41.4%) adults with dyspepsia required at least one visit to a medical practitioner/hospital as a result of dyspepsia in the 3-month period prior to the study ([Fig. 1](#F1){ref-type="fig"}). The majority of adults with dyspepsia consulted practitioners in rural health clinics (n = 53), with a small number attending private general practitioners. The median number of consultations over the 3-month period was 1 (range 1-3). None of the patients reported having sophisticated investigations such as endoscopy or radiological imaging.

One hundred and thirty-eight out of 292 adults with dyspepsia were in employment during the period of study. During the 3 months prior to the period of study, 42/138 (30.4%) adults with dyspepsia reported having to miss work due to dyspepsia. Dyspepsia resulted in a median of 1 (range 1-7, total 84) day off work over a 3-month period in the (n = 2,000) rural sample population studied ([Fig. 2](#F2){ref-type="fig"}).

Based on the cumulative costs from both societal and health service perspectives, the cost of dyspepsia in the rural population studied over a 3-month period was USD7,408.05 ([Table 4](#T4){ref-type="table"}). Extrapolating the data over a 12-month period, the total cost of dyspepsia per 1,000 adults per year in a rural Malaysian population was estimated at USD14,816.10. The mean EQ-5D utility score in the rural population with dyspepsia was 0.91 ± 0.07. Hence, the QALY associated with dyspepsia was estimated at 0.91 and the cost per QALY for an adult with dyspepsia in the rural population was USD16.30.

Cost of Dyspepsia in Urban Population
-------------------------------------

Dyspepsia was prevalent in 496 (24.3%) adults in the urban population. Two hundred and fifty-eight out of 496 (52.0%) adults with dyspepsia required medication regularly, for a minimum period of 4 weeks, to control their symptoms over a 3-month period. Of these, 157/258 bought over the counter drugs whilst the rest used medical prescriptions. The type of pharmaceutical and herbal compounds consumed were as follows: antacids (n = 195), H~2~ receptor antagonists (n = 19), proton pump inhibitors (n = 21), prokinetics (n = 4), anti-spasmodic (n = 6), simethicone (n = 4), traditional Malay preparations (n = 12), traditional Chinese preparations (n = 20) and Western herbal preparations (*Spirolina* \[micro-algae\]), \"Cat\'s claw\" \[*Uncaria tomentosa*\], \"Elm bark\" \[*Ulmus fulva*\] and garlic pearls) (n = 8).

One hundred and fourty-two (28.7%) adults with dyspepsia required at least one visit to a medical practitioner/hospital as a result of dyspepsia in the 3-month period prior to the study ([Fig. 1](#F1){ref-type="fig"}). The majority of adults with dyspepsia consulted private general practitioners (n = 98), with a minority attending government-run primary care clinics. All 29 patients who had visited private institutions were investigated with upper GI endoscopy and abdominal ultrasound scans, in addition to routine blood testing. The median number of consultations over the 3-month period was 1 (range 1-3).

One hundred and one (21.1%) adults with dyspepsia in the urban population reported having to miss work due to dyspepsia over a 3-month period. Dyspepsia resulted in a total of 349 days (median 2 days, interquartile range 1-4) off work over a 3-month period ([Fig. 2](#F2){ref-type="fig"}). The total cumulative direct and indirect cost of dyspepsia over a 3-month period was calculated at USD30,219.10 ([Table 4](#T4){ref-type="table"}). Extrapolating the data over a 12-month period, the total cost of dyspepsia per 1,000 adults per year among urban dwellers was estimated at USD59,282.20. The mean EQ-5D utility score in the urban population with dyspepsia was 0.85 ± 0.17. Hence the QALY associated with dyspepsia was estimated at 0.85 and the cost per QALY for an adult with dyspepsia in the urban population was USD69.75.

Discussion
==========

The method of economic evaluation used in this study has several advantages. Firstly, a prevalence-based, rather than an incidence-based approach, accounts for all cases in a given year and the estimate can be compared to measures of total annual health care expenditure. Secondly, a \"bottom-up\" rather than a \"top-down\" approach for cost estimation enables an in-depth investigation of the patient sample as this method starts from a selected sub-population with the actual disease and all costs related to the disease are estimated and then extrapolated to the national level.[@B23] The main potential disadvantage of this method is that the sample selected has to be representative and prevalence figures have to be accurate to enable a reasonable estimate for extrapolation of costings to the population at large. Nevertheless, economic evaluations of other diseases have demonstrated that a \"bottom-up\" approach provides a more realistic estimate of the cost of a disease to society compared to a \"top-down\" approach.[@B24]

In this population-based study of representative rural and urban Asian communities, we have demonstrated that the direct and indirect costs of dyspepsia was an estimated USD14,816.10 per 1,000 population in rural Malaysia, whilst the figure was USD59,282.20 per 1,000 population in urban Malaysia, during the financial year of 2007/2008. The difference in economic impact of dyspepsia between rural and urban Malaysians appears to be multi-factorial. For one, the prevalence of dyspepsia was significantly higher in the urban (24.3%) compared to the rural (14.6%) population. Epidemiological differences between both populations are the most likely cause for this difference in prevalence. A higher proportion of ethnic Indians and Chinese in the urban population, known to have more organic disease and *Helicobacter pylori* infection compared to ethnic Malays,[@B25],[@B26] is thought to be a major contributing factor for this difference.[@B3] This aside, urban adults with dyspepsia had greater drug consumption and more work absenteeism (349 days urban vs 84 days rural) over a 3-month period. The latter factor was additionally compounded by the higher mean monthly incomes among urban adults (USD1,504.90 ± 1,420.10 urban vs USD316.40 ± 220.44 rural), resulting in a greater economic impact from days lost from working.

Rural adults with dyspepsia had a higher medical consultation rate compared to urban dyspeptics. However, the cost of medical consultation was higher in urban patients due to the differences in healthcare provision between rural and urban areas. Rural health care in this country consists of highly subsidised small community clinics run by community nurses, and larger rural health clinics which are staffed by a single medical officer together with a team of paramedical staff.[@B27] In contrast, primary healthcare in urban Malaysia largely consists of privatized general practitioner clinics and many have direct access to specialist physician clinics in the community.[@B13] As previously mentioned, subsidised healthcare systems are similar in both rural and urban areas, but the delivery of this healthcare is different.

The impact of dyspepsia among urban, as compared to rural, adults with dyspepsia was not only evident in total costings alone. Dyspepsia resulted in a significant cost per QALY difference among urban dyspeptics when compared to their rural counterparts. To our knowledge, no study has demonstrated this disparity of intangible costs within nor between different populations. The exact explanation for this observation is uncertain at present. The nature of the Rome II questionnaire precluded any assessment of dyspepsia symptom severity or frequency among the study population. Both factors have been shown to influence dyspepsia-related consultation practices[@B28] and it is possible that dyspepsia symptoms were more severe among urban compared to rural adults with dyspepsia. Recent clinical trials in primary care have demonstrated that appropriate initial therapy can increase the cost per QALY gained in dyspepsia.[@B29] Urban adults with dyspepsia in this study had lower medical consultation rates and tended to self-medicate more, when compared to rural dyspeptics. It is hence possible that the cost per QALY lost for dyspepsia among urban adults may have been a reflection of less effective therapy in this group of patients.

Several community-based studies in the West have made similar evaluations of the economic impact of dyspepsia. In Sweden, investigators estimated that a 30% prevalence of dyspepsia resulted in a USD113,630.00 per 1,000 population economic burden back in 1991.[@B30] In a British study of 5,056 adults aged 40-49 years from 36 primary care centres, a 38% prevalence of dyspepsia was estimated to cost USD64,000 per 1,000 population for the period of 1992-1994.[@B31] A recent retrospective analysis of payroll data, adjudicated health insurance medical and prescription claims collected over a 4-year study period from more than 300,000 employees in the U.S. estimated that functional dyspepsia alone cost USD10,000,133.00 per 1,000 employees.[@B32] Taking inflation into account and the fact that the recent U.S. study was not community-based (hence only capturing data on adults in employment), it is apparent that dyspepsia in this Asian population cost far less than in the West, although no direct comparisons have been made to date. Although differences in healthcare systems and socioeconomic status clearly exist between Asian and Western countries,[@B33] additional factors such as cultural attitudes to healthcare seeking behavior may additionally contribute to lower costs of dyspepsia in the East.

Several limitations in this study need to be highlighted. Recall bias, as a consequence of relying on patients\' reports and not medical records, may have under or over estimated the costs of dyspepsia in both rural and urban populations. The natural history of dyspepsia is known to remit and relapse over a period of time, with symptoms even resolving in a minority of patients.[@B7],[@B34] Depending on the natural history of dyspeptic patients in this study sample, a 12-month extrapolation of 3 months\' worth of costing may again have either been over or under estimated. Although, a single time frame utility score of the EQ-5D was used to determine QALYs in this study, \"discounting\" was employed to minimize inaccuracies in tangible costs.[@B15]

In summary, we have demonstrated that direct, indirect and intangible costings for dyspepsia are considerable in a representative population in Asia. The economic consequences of dyspepsia are significantly greater in urban compared to rural adults with the condition. Differences in healthcare utilization, self-medication practices and socioeconomic status are partly responsible for these differences. This study provides data on the impact of dyspepsia in the Asian region which may be useful for healthcare planners and for investigators assessing more cost-effective measures in the management of dyspepsia.
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Gastrointestinal Symptoms Questionnaire
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Cost of Dyspepsia-Related Medications and Medical Resources in Malaysia in 2007/2008
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H~2~RA, H~2~ receptor antagonist; PPI, proton-pump inhibitor.
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Socioeconomic Status of Both Rural and Urban Study Population
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Details of Traditional Herbal Remedies Consumed by Malaysian Population
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Costing for Dyspepsia in Both Rural and Urban Population
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OTC, over the counter; QALY, quality-adjusted life year.
